Publicaciones (88) Publicaciones de MARIA CLARA ALVAREZ VILLAMARIN

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. Formulation of protein-loaded nanoparticles via freeze-drying

    Drug Delivery and Translational Research

  4. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe

    Endocrine, Vol. 83, Núm. 3, pp. 585-593

  5. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  6. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas (Oncogene, (2021), 40, 45, (6354-6368), 10.1038/s41388-021-02009-8)

    Oncogene

2022

  1. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  2. LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner

    Cells, Vol. 11, Núm. 3

  3. Tackling Thyroid Cancer in Europe—The Challenges and Opportunities

    Healthcare (Switzerland), Vol. 10, Núm. 9

  4. The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling

    Cancers, Vol. 13, Núm. 16

  2. Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis

    Cell Metabolism, Vol. 33, Núm. 9, pp. 1820-1835.e9

  3. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

  4. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

  5. Synthesis and in vivo evaluation of insulin-loaded whey beads as an oral peptide delivery system

    Pharmaceutics, Vol. 13, Núm. 5

  6. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  2. Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo

    Journal of Controlled Release, Vol. 317, pp. 118-129

  3. Molecular profiling for acromegaly treatment: a validation study

    Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389